TARA ISBELL: Open Payments
NPI 1235854712 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 31 payments from 12 companies in 2025. Trend: 2023 $337 · 2024 $413 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 6 | $158 |
| AstraZeneca Pharmaceuticals LP | 4 | $102 |
| Verona Pharma, Inc. | 3 | $84 |
| Regeneron Healthcare Solutions, Inc. | 4 | $70 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Actelion Pharmaceuticals US, Inc. | 2 | $46 |
| United Therapeutics Corporation | 2 | $45 |
| GENZYME CORPORATION | 2 | $44 |
| Electromed, Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $33 |
Products named: Prolastin-C Liquid, DUPIXENT, Ohtuvayre, FASENRA, UPTRAVI, Tyvaso, SMARTVEST, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
